Back to AMLX
PERCEPTIVE ADVISORS LLC → AMLX
PERCEPTIVE ADVISORS LLC AMLX Position History
Amylyx Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$307.7M
Q3 2026
Peak value
$307.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $100.1M |
| Q1 2026 | $115.2M |
| Q1 2026 | $115.2M |
| Q2 2026 | $149.7M |
| Q3 2026 | $307.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $307.7M | 10.57M | — | — |
| Q2 2026 | $149.7M | 8.33M | — | — |
| Q1 2026 | $115.2M | 8.28M | — | — |
| Q1 2026 | $115.2M | 8.28M | — | — |
| Q4 2025 | $100.1M | 8.28M | — | — |
Other funds holding AMLX
$460.9M
$261.7M
$201.3M
$174.7M
$153.5M
$153.4M